Peer review reports
From: Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy
Original Submission |
13 Dec 2014 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
Resubmission - Version 5 |
|
Submitted |
Manuscript version 5
|
Resubmission - Version 6 |
|
Submitted |
Manuscript version 6
|
|
Author responded |
Author comments
|
Resubmission - Version 7 |
|
Submitted |
Manuscript version 7
|
|
Author responded |
Author comments
|
|
Reviewed |
Reviewer Report
|
|
Reviewed |
Reviewer Report
|
|
Reviewed |
Reviewer Report
|
|
Reviewed |
Reviewer Report
|
|
Reviewed |
Reviewer Report
|
Resubmission - Version 8 |
|
Submitted |
Manuscript version 8
|
|
Author responded |
Author comments
|
Resubmission - Version 9 |
|
Submitted |
Manuscript version 9
|
Publishing |
19 May 2015 |
Editorially accepted |
|
19 Jun 2015 |
Article published |
10.1186/s12894-015-0040-7
|
Learn about peer review